Dec 16 2009
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today announced that it has completed the
previously announced acquisition of BioTrove, Inc. for an undisclosed
amount.
BioTrove’s primary technology is the OpenArray® platform, a
high throughput gene expression and genotyping analysis system based on
a flexible array format that enables researchers to perform more than
3,000 PCR genotyping or qPCR gene expression assays at a time.
As previously announced, Life Technologies does not expect this
transaction to have a material effect on its financials in fiscal year
2009.
http://www.lifetechnologies.com/